Spineway SA (FRA:37S)

Market Cap	3.15M
Revenue (ttm)	11.80M
Net Income (ttm)	-1.90M
Shares Out	n/a
EPS (ttm)	-0.06
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	1,111
Average Volume	1,559
Open	0.1676
Previous Close	0.1502
Day's Range	0.1560 - 0.1676
52-Week Range	0.0640 - 0.2625
Beta	n/a
RSI	52.21
Earnings Date	Feb 5, 2026

About Spineway

Spineway SA designs, develops, and markets a range of surgical implants for spine in France. The company offers posterior fixation, including posterior osteosynthesis systems and minimal invasive posterior osteosynthesis systems; interbody fusion products, such as lumbar cage twin peaks tlif curved and oblique; motion preservation products; and biomaterials. It also exports its products. The company was incorporated in 2005 and is headquartered in Ecully, France.

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 2005
• Employees: 49
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 37S

Financial Performance

In 2024, Spineway's revenue was 12.73 million, an increase of 12.11% compared to the previous year's 11.36 million. Losses were -3.87 million, -40.63% less than in 2023.